About NIBC Biogeneration Ventures:

NIBC Biogeneration Ventures (BGV) is a venture capital firm that invests in innovative early stage companies.

BGV mainly acts as lead investor, with over €220 million raised across four funds and 10 successful exits, since 2006.

Offer:

NIBC Biogeneration Ventures offer:

• Experience
• Extensive industry network
• Sector-relevant expertise
• Product development acceleration

Investment phase:

NIBC Biogeneration Ventures mainly invests in early-stage ventures.

Operating area:

NIBC Biogeneration Ventures focuses its investments within the European area.

Business investment categories:

NIBC Biogeneration Ventures mainly invests in life sciences companies working on:

• Medical innovation
• Healthcare innovation

Portfolio:

These are some companies that Biogeneration Ventures invested in:

• Bioceros: “offers cell line generation services related to the preclinical development of monoclonal antibodies”.
• Catalym: “develops antibodies against a placental factor which is overexpressed by various tumour types”.
• Surgvision: “develops fluorescence imaging systems including tracers for use in image-guided surgery”.

You can find the full portfolio of Biogeneration Ventures, here.

Get in touch with Biogeneration Ventures:

If you want to contact NIBC Biogeneration Ventures you can use:

• Phone Number: +31 (0) 35 699 30 00
• Email: info@biogeneration.vc
• Address:
  Gooimeer 2-35
  1411 DC Naarden
  The Netherlands

References
1. Biogeneration Ventures, accessed January 2021, https://www.biogenerationventures.com/